
JBIO vs ANRO
$JBIO vs $ANRO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
JBIO vs ANRO: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·ANRO has the cleaner trend, above both its 50- and 200-day averages, where JBIO is above one and below the other.
- ·Both beat the market over the past year: JBIO +22% and ANRO +65.6%, against the S&P 500 at +8.8%.
- ·JBIO sits closer to its support, 2.5% above it at $14.81, while ANRO is 14.3% above its own at $22.58.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
JBIO vs ANRO: the quick read
- ·JBIO is the larger company by market cap ($1.07B vs $1.04B).
- ·JBIO has been more active on our scanner (140 vs 112 alerts in 30 days).
- ·ANRO has the smaller float (38.2M vs 55.7M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 140 and 112 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching JBIO or ANRO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing JBIO and ANRO on TheDesperateTrader.
- Is JBIO or ANRO the better stock?
- "Better" depends on your goal, and these two are not alike. JBIO is the larger company by market cap ($1.07B vs $1.04B). JBIO has been more active on our scanner (140 vs 112 alerts in 30 days). ANRO has the smaller float (38.2M vs 55.7M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between JBIO and ANRO?
- The differences that matter: they are similar in size ($1.07B vs $1.04B); they trade at very different share prices ($15.19 vs $26.33); JBIO sits at 25% of its 52-week range against 55% for ANRO; our scanner flagged JBIO 140 times in the last 30 days against 112 for ANRO. Everything above is measured from the latest completed session and SEC filings.
- Which of JBIO and ANRO is more active right now?
- Right now JBIO is at about 0.9x its normal volume and ANRO is at about 1.5x, so ANRO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is JBIO or ANRO in the stronger trend?
- JBIO is above its 50-day average of $15.00 and below its 200-day average of $18.21; ANRO is above its 50-day average of $25.70 and above its 200-day average of $24.94. ANRO leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading JBIO or ANRO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore JBIO and ANRO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.